linkedin

Press Releases

Media Focus

Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy

MEDIA FOCUS 

MEDIA FOCUS

Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy

Youlim Kim

Lead Scientist, Cell Line Development

 

Technological advances in drug manufacturing equipment and process optimization play a significant role in increasing speed to market of critical biologic drugs. In this article, Youlim Kim, our Lead Scientist in Cell Line Development, explores the challenges associated with CLD and offers an expert look into the tactics CDMOs can employ to shorten commercial timelines while preserving quality and yield. 

 

Learn more (See page 44-45) 

 

 

MEDIA FOCUS 

MEDIA FOCUS

Achieving Faster Investigational New Drug Timelines with a Robust Cell Line Development Strategy

Youlim Kim

Lead Scientist, Cell Line Development

 

Technological advances in drug manufacturing equipment and process optimization play a significant role in increasing speed to market of critical biologic drugs. In this article, Youlim Kim, our Lead Scientist in Cell Line Development, explores the challenges associated with CLD and offers an expert look into the tactics CDMOs can employ to shorten commercial timelines while preserving quality and yield. 

 

Learn more (See page 44-45) 

 

 

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
close

SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core technology and management information, as well as reinforcing domestic competency and economic development.

  • This page is created for reporting core technology and management information leakage.
  • The reported contents as well as the identity of the reporter are strictly secured.
THE MANUAL FOR SECURITY NOTIFICATION

Copyright Samsung Biologics. All rights reserved